These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30794831)

  • 1. Leakage current from transvenous and subcutaneous implantable cardioverter defibrillators (ICDs): A risk to the rescuer?
    Petley GW; Albon B; Banks P; Roberts PR; Deakin CD
    Resuscitation; 2019 Apr; 137():148-153. PubMed ID: 30794831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leakage of energy to the body surface during defibrillation shock by an implantable cardioverter-defibrillator (ICD) system--experimental evaluation during defibrillation shocks through the right ventricular lead and the subcutaneous active-can in canines.
    Niwano S; Kitano Y; Moriguchi M; Yoshizawa N; Kashiwa T; Suyama M; Toyoshima T; Izumi T
    Jpn Circ J; 2001 Mar; 65(3):219-25. PubMed ID: 11266198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.
    Killingsworth CR; Melnick SB; Litovsky SH; Ideker RE; Walcott GP
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1265-72. PubMed ID: 23713608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical injury during "hands on" defibrillation-A potential risk of internal cardioverter defibrillators?
    Stockwell B; Bellis G; Morton G; Chung K; Merton WL; Andrews N; Smith GB
    Resuscitation; 2009 Jul; 80(7):832-4. PubMed ID: 19446388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the safety of subcutaneous versus transvenous ICDs: a meta-analysis.
    Su L; Guo J; Hao Y; Tan H
    J Interv Card Electrophysiol; 2021 Apr; 60(3):355-363. PubMed ID: 33432473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.
    Pun PH; Parzynski CS; Friedman DJ; Sanders G; Curtis JP; Al-Khatib SM
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1622-1630. PubMed ID: 32967922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hands-on defibrillation: theoretical and practical aspects of patient and rescuer safety.
    Petley GW; Cotton AM; Deakin CD
    Resuscitation; 2012 May; 83(5):551-6. PubMed ID: 22094984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ventricular tachycardia by alternate current due to an insufficiently grounded electrical system.
    Lappegård KT
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e170-2. PubMed ID: 21091734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators and the pathologist: comment and cautionary notes.
    Walley VM; Bourke ME; Green M; Stinson WA; Veinot JP
    J Forensic Sci; 1998 Sep; 43(5):969-73. PubMed ID: 9729813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of body surface energy leakage of defibrillation shock by an implantable cardioverter defibrillator.
    Niwano S; Kojima J; Inuo K; Saito J; Kashiwa T; Suyama M; Toyoshima T; Aizawa Y; Izumi T
    Pacing Clin Electrophysiol; 2002 Aug; 25(8):1212-8. PubMed ID: 12358172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.
    Friedman DJ; Parzynski CS; Heist EK; Russo AM; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
    Circulation; 2018 Jun; 137(23):2463-2477. PubMed ID: 29463509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator-an unusual case of inappropriate discharge during showering.
    Manolis AG; Katsivas AG; Vassilopoulos CV; Louvros NE
    J Interv Card Electrophysiol; 2000 Apr; 4(1):265-8. PubMed ID: 10729845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Subcutaneous Implantable Cardioverter Defibrillator.
    Mangels D; Frishman WH
    Cardiol Rev; 2016; 24(5):248-55. PubMed ID: 26807549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.